NASDAQ : RETA

Reata Pharmaceuticals, Inc.

$172.36 USD

$0.04 (0.02%)

Volume
1.91M
Average Volume
969.32K
Market Capitalization
$6.57B
P/E Ratio
-20.07
Dividend Yield
0.00%
Price Target
$46.00
Year High
$172.46
Year Low
$21.83
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$6.75
Source Headline

Get RETA Insider Trade Alerts

RETA Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$67.40

5 analysts

RETA Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2023-08-15 Cantor Fitzgerald Maintain Neutral Neutral
2023-08-14 Cantor Fitzgerald Maintain Neutral Neutral
2023-08-01 Citigroup Downgrade Buy Neutral
2023-08-01 Barclays Downgrade Overweight Equal Weight
2023-07-31 Jefferies Downgrade Buy Hold
2023-07-31 Citigroup Downgrade Buy Neutral
2023-07-31 Barclays Downgrade Overweight Equal Weight
2023-07-31 Ladenburg Thalmann Downgrade Buy Neutral
2023-07-31 Baird Maintain Outperform Outperform
2023-07-30 Ladenburg Thalmann Downgrade Buy Neutral
2023-07-30 Baird Maintain Outperform Outperform
2023-07-30 Jefferies Downgrade Buy Hold
2023-07-28 Stifel Downgrade Buy Hold
2023-07-27 Stifel Downgrade Buy Hold
2023-07-24 Cantor Fitzgerald Maintain Overweight Overweight
2023-07-23 Cantor Fitzgerald Maintain Overweight Overweight
2023-06-29 Ladenburg Thalmann Maintain Buy Buy
2023-06-28 Cantor Fitzgerald Maintain Overweight Overweight
2023-06-28 Barclays Maintain Overweight Overweight
2023-06-28 Ladenburg Thalmann Maintain Buy Buy
2023-06-27 Cantor Fitzgerald Maintain Overweight Overweight
2023-06-27 Barclays Maintain Overweight Overweight
2023-06-12 SVB Leerink Upgrade Market Perform Outperform
2023-06-11 SVB Leerink Upgrade Market Perform Outperform
2023-05-11 Barclays Maintain Overweight Overweight
2023-05-10 Barclays Maintain Overweight Overweight
2023-04-13 Stifel Maintain Buy Buy
2023-04-12 Stifel Maintain Buy Buy
2023-03-27 Cantor Fitzgerald Maintain Overweight Overweight
2023-03-26 Cantor Fitzgerald Maintain Overweight Overweight
2023-03-01 Goldman Sachs Maintain Buy Buy
2023-03-01 Baird Maintain Neutral Neutral
2023-03-01 Cantor Fitzgerald Maintain Overweight Overweight
2023-03-01 Citigroup Maintain Buy Buy
2023-03-01 Barclays Maintain Overweight Overweight
2023-02-28 Goldman Sachs Maintain Buy Buy
2023-02-28 Baird Maintain Neutral Neutral
2023-02-28 Barclays Maintain Overweight Overweight
2023-02-28 Cantor Fitzgerald Maintain Overweight Overweight
2023-02-28 Citigroup Maintain Buy Buy
2023-02-24 Goldman Sachs Maintain Buy Buy
2023-02-23 Goldman Sachs Maintain Buy Buy
2022-11-28 Goldman Sachs Maintain Buy Buy
2022-11-27 Goldman Sachs Maintain Buy Buy
2022-11-09 Barclays Maintain Overweight Overweight
2022-11-09 Goldman Sachs Maintain Buy Buy
2022-11-09 Citigroup Maintain Buy Buy
2022-11-08 Citigroup Maintain Buy Buy
2022-11-08 Goldman Sachs Maintain Buy Buy
2022-11-08 Barclays Maintain Overweight Overweight
2022-08-09 Baird Maintain Neutral Neutral
2022-08-08 Baird Maintain Neutral Neutral
2022-05-27 Citigroup Maintain Buy Buy
2022-05-26 Citigroup Maintain Buy Buy
2022-05-24 Goldman Sachs Maintain Buy Buy
2022-05-23 Goldman Sachs Maintain Buy Buy
2022-03-24 Goldman Sachs Upgrade Neutral Buy
2022-03-23 Goldman Sachs Upgrade Neutral Buy
2022-03-01 Goldman Sachs Maintain Neutral Neutral
2022-02-28 Goldman Sachs Maintain Neutral Neutral
2021-12-09 SVB Leerink Downgrade Outperform Market Perform
2021-12-09 Barclays Maintain Overweight Overweight
2021-12-09 Baird Downgrade Outperform Neutral
2021-12-09 Goldman Sachs Downgrade Buy Neutral
2021-12-08 SVB Leerink Downgrade Outperform Market Perform
2021-12-08 Baird Downgrade Outperform Neutral
2021-12-08 Goldman Sachs Downgrade Buy Neutral
2021-12-08 Cantor Fitzgerald Maintain Overweight Overweight
2021-12-08 Barclays Maintain Overweight Overweight
2021-05-20 Citigroup Maintain Buy Buy
2021-05-19 Citigroup Maintain Buy Buy
2020-08-11 Citigroup Maintain Buy Buy
2020-08-10 Citigroup Maintain Buy Buy
2020-05-18 Cantor Fitzgerald Maintain Overweight Overweight
2020-05-17 Cantor Fitzgerald Maintain Overweight Overweight
2020-03-31 Baird Maintain Outperform Outperform
2020-03-31 Stifel Maintain Buy Buy
2020-03-31 Citigroup Maintain Buy Buy
2020-03-30 Citigroup Maintain Buy Buy
2020-03-30 Baird Maintain Outperform Outperform
2020-03-30 Stifel Maintain Buy Buy
2019-11-12 Citigroup Maintain Buy Buy
2019-11-11 Citigroup Maintain Buy Buy
2019-11-04 Cantor Fitzgerald Maintain Overweight Overweight
2019-11-03 Cantor Fitzgerald Maintain Overweight Overweight
2019-10-16 Stifel Maintain Buy Buy
2019-10-15 Cantor Fitzgerald Maintain Overweight Overweight
2019-10-15 Citigroup Maintain Buy Buy
2019-10-15 Jefferies Maintain Buy Buy
2019-10-15 Stifel Maintain Buy Buy
2019-10-14 Citigroup Maintain Buy Buy
2019-10-14 Cantor Fitzgerald Maintain Overweight Overweight
2019-10-14 Jefferies Maintain Buy Buy
2019-05-31 Citi Maintain Buy Buy
2019-05-30 Citigroup Maintain Buy Buy
2018-07-25 Citigroup Maintain Buy Buy
2018-07-24 Citigroup Maintain Buy Buy
2018-07-24 Baird Maintain Outperform Outperform
2018-07-23 Citigroup Maintain Buy Buy
2018-07-23 Baird Maintain Outperform Outperform
2017-08-23 Citigroup Maintain Buy Buy
2017-08-22 Citigroup Maintain Buy Buy